arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Cryoport, Inc.

CYRX
$16.02 ▼ -0.67 (-4.01%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
67 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
45
Health
Weak
Moderately Bullish
auto_awesome

Analytical Summary

Cryoport, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). However, watch Operating Margin (%) which shows concerning trends. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $808.1M
Dividend Yield —
Revenue Growth 7.7% ↘
Op. Margin -20.5% →
ROIC -2.2% ↘
FCF / Share $-0.16 ↘
Trailing P/E —
Price / Book 1.7x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$48.97M
↑ +7.7% —
Net Income Profit after all expenses
$-8.26M
↑ +21.7% —
Operating Margin Operating profit as % of sales
-20.5%
↓ -1.9% 10th
FCF / Share Free cash flow per share
$-0.16
↑ +32.1% —
Long-Term Debt Long-term obligations
$1.29M
↑ +297.9% —
trending_up

Bullish Indicators

  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
39
Returns
81
Financial Health ↓
23
Cash Quality
15

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 17 years · 67 quarters